ARVN
Price
$18.48
Change
+$0.65 (+3.65%)
Updated
Dec 20, 04:59 PM (EDT)
71 days until earnings call
LYRA
Price
$0.18
Change
+$0.01 (+5.88%)
Updated
Dec 20 closing price
72 days until earnings call
Ad is loading...

ARVN vs LYRA

Header iconARVN vs LYRA Comparison
Open Charts ARVN vs LYRABanner chart's image
Arvinas
Price$18.48
Change+$0.65 (+3.65%)
Volume$12.62K
CapitalizationN/A
Lyra Therapeutics
Price$0.18
Change+$0.01 (+5.88%)
Volume$2.25M
CapitalizationN/A
ARVN vs LYRA Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. LYRA commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and LYRA is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ARVN: $18.48 vs. LYRA: $0.18)
Brand notoriety: ARVN and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 221% vs. LYRA: 109%
Market capitalization -- ARVN: $1.27B vs. LYRA: $11.78M
ARVN [@Biotechnology] is valued at $1.27B. LYRA’s [@Biotechnology] market capitalization is $11.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, LYRA is a better buy in the long-term than ARVN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while LYRA’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 6 bearish.
  • LYRA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LYRA is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а -5.23% price change this week, while LYRA (@Biotechnology) price change was -1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ARVN is expected to report earnings on Mar 03, 2025.

LYRA is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($1.27B) has a higher market cap than LYRA($11.8M). ARVN YTD gains are higher at: -55.102 vs. LYRA (-96.565). LYRA has higher annual earnings (EBITDA): -67.04M vs. ARVN (-350.6M). ARVN has more cash in the bank: 1.12B vs. LYRA (51.6M). ARVN has less debt than LYRA: ARVN (1.5M) vs LYRA (35.3M). ARVN has higher revenues than LYRA: ARVN (161M) vs LYRA (1.47M).
ARVNLYRAARVN / LYRA
Capitalization1.27B11.8M10,763%
EBITDA-350.6M-67.04M523%
Gain YTD-55.102-96.56557%
P/E RatioN/AN/A-
Revenue161M1.47M10,945%
Total Cash1.12B51.6M2,174%
Total Debt1.5M35.3M4%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNLYRA
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 24 days ago
81%
Bullish Trend 21 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
64%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRVRX8.110.13
+1.63%
NYLI CBRE Real Estate Fund Investor Cl
CCRIX25.020.19
+0.77%
Columbia Small Cap Growth R
APHNX15.310.09
+0.59%
Artisan Select Equity Institutional
LGRRX26.670.01
+0.04%
Loomis Sayles Growth A
FITMX13.59-0.05
-0.37%
Fidelity SAI International Mtm Idx

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with CRBU. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
+3.65%
CRBU - ARVN
51%
Loosely correlated
-0.55%
ABCL - ARVN
49%
Loosely correlated
+5.17%
SNDX - ARVN
48%
Loosely correlated
+1.79%
AURA - ARVN
47%
Loosely correlated
+1.11%
AXON - ARVN
46%
Loosely correlated
+2.60%
More